Bräuer Pia, Anielski Patricia, Schwaiger Stefan, Stuppner Hermann, Tran Thi Van Anh, Vollmer Günter, Zierau Oliver, Thieme Detlef, Keiler Annekathrin Martina
Institute of Doping Analysis and Sports Biochemistry Dresden, Germany.
Institute of Pharmacy/Pharmacognosy, University of Innsbruck, Austria.
Drug Test Anal. 2019 Jan;11(1):86-94. doi: 10.1002/dta.2449. Epub 2018 Aug 9.
Eurycoma longifolia Jack (Tongkat Ali, Simaroubaceae) is a medicinal plant endemic to South-East Asia. For centuries, different parts of the plant have been used as a natural remedy to treat fever, hypertension, or sexual insufficiency. Today, Eurycoma longifolia preparations are commercially available and advertised to enhance athletic performance and muscle strength. Several studies have demonstrated a testosterone-boosting effect that might be caused by the release of free testosterone from the sex-hormone-binding globulin. To date, many phytochemical constituents of Eurycoma longifolia root extracts have been identified and physiological effects have been examined, while studies on their biotransformation and monitoring are still lacking. Within this study, eurycomalide C, eurycomalactone, 5,6-dehydro-eurycomalactone, longilactone, 14,15β-dihydroklaieanone, 11-dehydroklaieanone, 9-hydroxycanthin-6-one, and 9-methoxycanthin-6-one isolated from E. longifolia root were incubated with liver microsomes. Respective metabolites were analyzed by liquid chromatography-tandem (high-resolution) mass spectrometry. The compounds were chosen based on their potential androgenic effects (estimated by in vitro assays), their concentrations in plant extracts, and presumptive metabolic pathways. Hydroxylated phase I metabolites were only observed for 5,6-dehydro-eurycomalactone, 11-dehydroklaieanone, 9-hydroxycanthin-6-one, and 9-methoxycanthin-6-one. Moreover, an O-demethylated metabolite of 9-methoxycanthin-6-one was found. Besides, the glucuronide of 9-hydroxycanthin-6-one was detected after in vitro glucuronidation using liver microsomes. The in vitro generated metabolites were comparable to that detected in urine and serum after a single ingestion of either 9-methoxycanthin-6-one or an Eurycoma longifolia root extract. Hence, 9-methoxycanthin-6-one, its glucuronide, and the glucuronide of its O-demethylated biotransformation product are proposed to be the most suitable targets for detection of 9-methoxycanthin-6-one or Tongkat Ali application in urine and serum.
长叶刺蒺藜草(东革阿里,苦木科)是一种东南亚特有的药用植物。几个世纪以来,该植物的不同部位一直被用作治疗发烧、高血压或性功能不全的天然药物。如今,长叶刺蒺藜草制剂已商业化销售,并宣传其可提高运动表现和肌肉力量。多项研究表明,其具有促进睾酮分泌的作用,这可能是由于性激素结合球蛋白释放游离睾酮所致。迄今为止,长叶刺蒺藜草根提取物的许多植物化学成分已被鉴定,其生理效应也已得到研究,但对其生物转化和监测的研究仍很缺乏。在本研究中,从长叶刺蒺藜草根中分离出的刺蒺藜内酯C、刺蒺藜内酯、5,6-脱氢刺蒺藜内酯、长叶内酯、14,15β-二氢克莱安酮、11-脱氢克莱安酮、9-羟基-6-酮基咔啉和9-甲氧基-6-酮基咔啉与肝微粒体一起孵育。通过液相色谱-串联(高分辨率)质谱法分析各自的代谢产物。这些化合物是根据其潜在的雄激素效应(通过体外试验估计)、在植物提取物中的浓度以及推测的代谢途径来选择的。仅在5,6-脱氢刺蒺藜内酯、11-脱氢克莱安酮、9-羟基-6-酮基咔啉和9-甲氧基-6-酮基咔啉中观察到了羟基化的I相代谢产物。此外,还发现了9-甲氧基-6-酮基咔啉的O-去甲基化代谢产物。此外,在使用肝微粒体进行体外葡萄糖醛酸化后,检测到了9-羟基-6-酮基咔啉的葡萄糖醛酸苷。体外产生的代谢产物与单次摄入9-甲氧基-6-酮基咔啉或长叶刺蒺藜草根提取物后在尿液和血清中检测到的代谢产物相当。因此,9-甲氧基-6-酮基咔啉及其葡萄糖醛酸苷以及其O-去甲基化生物转化产物的葡萄糖醛酸苷被认为是在尿液和血清中检测9-甲氧基-6-酮基咔啉或东革阿里应用的最合适靶点。